Thursday, January 23, 2020

HER pathway and cancer



Dietmar Berger, vice president of clinical oncology at Genentech, discussed the role of the HER2 receptor in metastatic breast cancer.
Orignal From: HER pathway and cancer

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)